Back

Future direction for research in lipids.

28 August 2016 (15:12 - 15:30)
Organised by:
Congress Presentation Part of: Lipoproteins and real life: what the randomized clinical trials do not show us Epidemiology, lipids ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Eric Bruckert

University Pierre & Marie Curie Paris VI, Paris (France)

4 More presentations in this session

Presentation thumbnail
State of the art in lipoproteins: lessons from real life registries
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012
Doctor S. Martin (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.
Mr G. Berkelmans (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study
Professor W. Koenig (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and real life: what the randomized clinical trials do not show us

The Event

Event poster

ESC Congress 2016

28 August 2016 15:12 CET
You may be interested in
thumbnail
Congress Presentation
Lipidomics to fine-tune cardiovascular risk prediction and personalised treatment
3 April 2025
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Webinar
Arrhythmias and metabolic pathways: new mechanisms, new opportunities
2 June 2022
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources